Description
Antagonist G is a peptide used to target and enhance the delivery of anticancer chemotherapeutics.
Antagonist G
Product ID A5476
Cas No. 115150-59-9
Purity ≥95%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Cas No. | 115150-59-9 |
|---|---|
| Purity | ≥95% |
| Formula | C49H66O6N12S |
| Formula Wt. | 951.2 |
| IUPAC Name | (2S)-2-[[(2R)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]-methylamino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]-4-methylpentanamide |
| Solubility | Soluble in water (1 mg/mL). |
Shipping and Storage
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
Moreira JN, Gaspar R. Antagonist G-mediated targeting and cytotoxicity of liposomal doxorubicin in NCI-H82 variant small cell lung cancer. Braz J Med Biol Res. 2004 Aug;37(8):1185-92. PMID: 15273819.